[[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as Potent Antihyperglycemic Agents

Journal of Medicinal Chemistry

Volumn 37, Issue 23, 1994, Pages 3977-3985

  Cantello, Barrie C C ^a   Cawthorne, Michael A ^a   Cottam, Graham P ^a   Duff, Peter T ^a   Haigh, David ^a   Hindley, Richard M ^a   Lister, Carolyn A ^a   Smith, Stephen A ^a   Thurlby, Peter L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 [4 (2 UREIDOETHOXY)BENZYL] 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 [[4 [2 (2 BENZOXAZOLYLMETHYLAMINO)ETHOXY]PHENYL]METHYL] 2,4 THIAZOLIDINEDIONE; ANTIDIABETIC AGENT; ENGLITAZONE; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG POTENCY; HEMOGLOBIN DETERMINATION; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; STRUCTURE ACTIVITY RELATION;

ANIMAL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DISEASE MODELS, ANIMAL; HEMOGLOBINS; HYPOGLYCEMIC AGENTS; MICE; MICE, INBRED C57BL; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0027988554     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00049a017     Document Type: Article

References (27)

1. DeFronzo, R. A.; Bonadonna, R. C.; Ferrannini, E. Pathogenesis of NIDDM. Diabetes Care 1992, 15, 318—368.
2. Reaven, G. Role of Insulin Resistance in Human Disease. Diabetes 1988, 37, 1595-1607.
3. Ruderman, N. B.; Schneider, S. H. Diabetes, Exercise and Atherosclerosis. Diabetes Care 1992, 15 (Suppl. 4), 1787-1793.
4. Holman, R. R.; Turner, R. C. Oral Agents and Insulin in the Treatment of Non-Insulin Dependent Diabetes Mellitus. Textbook of Diabetes; Pickup, J. C., Williams, G. Eds.; Blackwell Scientific Publications: London, 1991; pp 462-476.
5. Turner, R. C.; Holman, R. R.; Matthews, D. R. Non-insulin dependent diabetes mellitus, Satellite Symposium of 13th IDDF; Cameron, D., Colagiui, S., Heding, L., Kühl, C., Ma, A., Mortimer, R., Eds.; Excerpta Medica: Amsterdam, 1988; pp 52-56.
6. The Diabetes Control and Complications Trial (DCCT). N. Engl. J. Med. 1993, 329, 683-689.
7. American Diabetic Association. Diabetes 1993, 43, 1555-1558.
8. Sohda, T.; Mizuno, K.; Tawada, H.; Sugiyama, Y.; Fujita, T.; Kawamatsu, Y. Studies on Antidiabetic Agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ADD-3878) and its Derivatives. Chem. Pharm. Bull. 1982,30, 3580-3600.
9. Meguro, K.; Fujita, T. Thiazolidinedione Derivatives, Their Production and Use. EP 0155845, 1985.
10. Yoshioka, T.; Kitazawa, E.; Yamazaki, M.; Hasegawa, K. Thiazolidinedione Derivatives, Their Preparation and Compositions Containing Them. European Patent No. 0139421, 1984.
11. Eggler, J. F. Hypoglycaemic Thiazolidinediones. U.S. Patent 4,738,972, 1985.
12. Lipinski, C. A.; Fiese, E. F.; Korst, R. J. pKa, LogP and MedChem CLog P Fragment Values of Acidic Heterocyclic Potential Bioisosteres. Quant. Struct.-Act. Relat. 1991, 10, 109-117.
13. Williams, G. D.; Deldar, A.; Jordan, W. H.; Gries, C.; Long, G. L.; Dimarchi, R. D. Subchronic toxicity of the thiazolidinedione, Tanabe-174 (LY 282449) in the rat and dog. Diabetes 1993, 52 (Suppl. 1), 59A.
14. Megura, K.; Fujita, T. Thiazolidinedione derivatives, their production and use. European Patent No. 0193256, 1986.
15. Watt, D. S.; Profitt, J. A.; Corey, E. J. A Reagent for the α,β Reduction of Conjugated Nitriles. J. Org. Chem. 1975, 40, 127-128.
16. Cantello, B. C. C.; Bindley, R. M. Urea and Thiourea Antihyperglycaemic Agents. European Patent No. 0295,828, 1988.
17. Cohen, N.; Weber, G. F. Phenoxyalkoxy-3,4-dihydro-2H-1-benzopyran Derivatives. European Patent No. 0129,906, 1985.
18. Sohda, T.; Meguro, K.; Kawamatsu, Y. Studies on Antidiabetic Agents. IV. Synthesis and Activity of the Metabolites of 5-[4-(l-Methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (Ciglitazone). Chem. Pharm. Bull. 1984, 32, 2267-2278.
19. Meaguro, K.; Fujita, T. Thiazolidinedione Derivatives, Their Production and Use. European Patent No. 0155848, 1985.
20. Burger, A. Isosterism and Bioisosterism in Drug Design. Prog. Drug. Res. 1991, 37, 347.
21. Sohda, T.; Momose, Y.; Meguro, K.; Sugiyama, Y.; Ikeda, H. Studies on Antidiabetic Agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones. Arzneim.-Forsch./Drug Res. 1990, 40 (1), 37-42.
22. Momose, Y.; Meguro, K.; Ikeda, H.; Hatanaka, C.; Satoru, O.; Sohda, T. Chem. Pharm. Bull. 1991, 39, 1440-1445.
23. Bergmeyer, H.-U.; Bernt, E.; Schmidt, F. H.; Stork, H. In Methods of Enzymatic Analysis, 2nd ed.; Bergmeyer, H.-U., Ed.; Academic Press: New York, 1974; p 1196.
24. Phillips, G. M.; Taylor, P. J. Theory and Applications of Numerical Analysis; Academic Press: London and New York, 1973; p 131.
25. Haigh, D. Heterocyclic compounds and their use in the treatment of Type diabetes. International Patent Application, Publication No. WO 93/21166, 1993.
26. Hindley, R. M. 5-Benzyl-2,4-oxazolidinediones. International Patent Application, Publication No. WO 92/02520, 1992.
27. Selegny, E.; Thoai, N.; Vert, M. Preparation of Racemic and Optically Active Polyelectrolytes and Ion Exchange by Poly-Condensation of Phenol Succinic acids with Formaldehyde. C. R., Ser. C 1966, 262 (2), 189-192.